| Literature DB >> 24053144 |
Angel Rosas-Aguirre1, Alejandro Llanos-Cuentas, Niko Speybroeck, Jackie Cook, Juan Contreras-Mancilla, Veronica Soto, Dionicia Gamboa, Edwar Pozo, Oscar J Ponce, Mayne O Pereira, Irene S Soares, Michael Theisen, Umberto D'Alessandro, Annette Erhart.
Abstract
BACKGROUND: Where malaria endemicity is low, control programmes need increasingly sensitive tools for monitoring malaria transmission intensity (MTI) and to better define health priorities. A cross-sectional survey was conducted in a low endemicity area of the Peruvian north-western coast to assess the MTI using both molecular and serological tools.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24053144 PMCID: PMC3849384 DOI: 10.1186/1475-2875-12-339
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Study area in Bellavista district (Piura department, northwestern coast of Peru) including three settlements. Pavletich (PAV), Jose Carlos Mariátegui (JCM) and Nuevo Porvenir (NP).
Baseline characteristics of the study population (N = 2,667)
| | | ||
| | Pavletich (PV) | 1,128 | 42.3 |
| José Carlos Mariategui (JCM) | 797 | 29.9 | |
| Nuevo Porvenir (NP) | 742 | 27.8 | |
| | | ||
| | <100 | 183 | 6.9 |
| 100–250 | 1401 | 52.5 | |
| >250 | 1,083 | 40.6 | |
| | | ||
| | Female | 1,628 | 61.0 |
| Male | 1,039 | 39.0 | |
| | | ||
| | 0–5 | 447 | 16.8 |
| 6–10 | 404 | 15.1 | |
| 11–19 | 491 | 18.4 | |
| 20–39 | 889 | 33.3 | |
| > = 40 | 436 | 16.4 | |
| | | ||
| | None | 44 | 3.1 |
| Primary | 517 | 36.4 | |
| Secondary | 689 | 48.5 | |
| Superior | 171 | 12.0 | |
| | | ||
| | None | 2,081 | 78.0 |
| < 650 PEN | 458 | 17.2 | |
| > = 650 PEN | 83 | 3.1 | |
| Missing | 45 | 1.7 | |
| | | ||
| | None (children, students, retired) | 1,319 | 49.5 |
| Farmer | 41 | 1.5 | |
| Moto-taxi driver | 74 | 2.8 | |
| Housewife | 723 | 27.1 | |
| Trader | 172 | 6.4 | |
| Laborer (indoor, manual worker) | 240 | 9.0 | |
| Others | 98 | 3.7 | |
| | | ||
| | No | 2,604 | 97.6 |
| Yes | 63 | 2.4 | |
| | | ||
| | No | 2,598 | 97.4 |
| Yes | 69 | 2.6 | |
| | | ||
| | Never/Sometimes | 1,250 | 46.9 |
| Always | 1,402 | 52.6 | |
| Missing | 15 | 0.5 | |
| | | ||
| No | 2,360 | 88.5 | |
| Yes (1 episode) | 273 | 10.2 | |
| Yes (> = 2 episodes) | 34 | 1.3 | |
*Income expressed in Peruvian nuevos soles (PEN). The official vital minimum wage in Peru is 650 PEN (approx 230 USD).
Malaria prevalence (by microscopy and PCR) and seroprevalence
| 8 | 2,667 | 0.3 | [0.2; 0.6] | ||
| Parasite density/μl, median [range] | 432 [112; 1,529] | | | ||
| 25 | 2,667 | 0.9 | [0.7; 1.4] | ||
| | 1 | 2,667 | 0.04 | [0.01; 0.3] | |
| | Any species | 26 | 2,667 | 1 | [0.6; 1.4] |
| PvMSP119 | 360 | 2,653 | 13.6 | [12.2; 15.1] | |
| | PfGLURP | 259 | 2,653 | 9.8 | [8.6; 11.1] |
| Total | 567 | 2,653 | 21.4 | [19.7; 23.1] | |
Association between PCR results and microscopy, serology and symptoms
| | ||||||
|---|---|---|---|---|---|---|
| | ||||||
| | | | | | ||
| | Negative | 2,642 | 100 | 17 | 68.0 | <0.001 |
| Positive | 0 | 0 | 8 | 32.0 | | |
| | | | | | ||
| | Negative | 2,282 | 86.8 | 11 | 44.0 | <0.001 |
| Positive | 346 | 13.2 | 14 | 56.0 | | |
| | | | | | ||
| | Negative | 2,369 | 90.2 | 22 | 88.0 | 0.71 |
| Positive | 256 | 9.8 | 3 | 12.0 | | |
| | | | | | ||
| | No | 2,592 | 98.1 | 22 | 88.0 | <0.001 |
| Yes | 50 | 1.9 | 3 | 12.0 | ||
Multivariate adjusted analysis for the risk of exposure to using survey logistic regression
| | | | | | | | | ||
| | PAV | 12.7 | [10.8; 14.9] | 143 | 1,123 | 1.0 | | - | |
| JCM | 15.6 | [13.1; 18.5] | 123 | 789 | 1.3 | [0.95; 1.7] | - | | |
| NP | 12.7 | [10.0; 15.9] | 94 | 741 | 1.0 | [0.7; 1.4] | - | | |
| | | | | | | | | ||
| | >250 | 9.5 | [7.8; 11.6] | 103 | 1,080 | 1.0 | | 1.0 | |
| 100–250 | 15.6 | [13.6; 17.9] | 217 | 1,391 | 1.8* | [1.3; 2.3] | 1.8* | [1.4; 2.4] | |
| <100 | 22.0 | [16.2; 29.2] | 40 | 182 | 2.7* | [1.7; 4.1] | 2.8* | [1.8; 4.4] | |
| | | | | | | | | ||
| | 0.5–5 | 6.7 | [4.7; 9.4] | 29 | 433 | 1.0 | | 1.0° | |
| 6–10 | 8.9 | [6.5; 12.1] | 36 | 404 | 1.4 | [0.8; 2.2] | | | |
| 11–19 | 13.9 | [10.7; 16.7] | 68 | 491 | 2.2* | [1.4; 3.5] | 2.1*∞ | [1.6; 2.8] | |
| 20–39 | 15.8 | [13.4; 18.4] | 140 | 889 | 2.6* | [1.7; 3.9] | | | |
| > = 40 | 20.0 | [16.5; 24.0] | 87 | 436 | 3.5* | [2.2; 5.4] | 3.1* | [2.2; 4.4] | |
| | | | | | | | | ||
| | None | 8.1 | [6; 10.8] | 39 | 483 | 1.0 | | - | |
| Primary | 13.3 | [11.3; 15.7] | 140 | 1,199 | 1.8* | [1.2; 2.5] | - | | |
| Secondary | 16.3 | [14; 19] | 153 | 829 | 2.2* | [1.5; 3.2] | - | | |
| Superior | 15.1 | [10.7; 20.9] | 27 | 141 | 2.0* | [1.2; 3.4] | - | | |
| | | | | | | | | ||
| | None | 12.6 | [11.1; 14.3] | 261 | 2,067 | 1.0 | | - | |
| < 650 PEN | 17.9 | [14.7; 21.7] | 82 | 458 | 1.5* | [1.2; 2] | - | | |
| > = 650 PEN | 14.5 | [8.4; 23.8] | 12 | 83 | 1.3 | [0.6; 2.2] | - | | |
| | | | | | | | | ||
| | No | 13.3 | [11.9; 14.8] | 344 | 2,590 | 1.0 | | - | |
| Yes | 25.4 | [16.3; 37.3] | 16 | 63 | 2.2* | [1.3; 3.9] | - | | |
| | | | | | | | | ||
| | Never/Sometimes | 13.4 | [12.1; 14.9] | 347 | 2,584 | 1.0 | | - | |
| Always | 18.8 | [11.2; 30.0] | 13 | 69 | 1.5 | [0.8; 2.8] | - | | |
| | | | | | | | | ||
| | No | 13.0 | [11.1; 15.2] | 162 | 1,244 | 1.0 | | - | |
| Yes | 14.1 | [12.2; 16.2] | 196 | 1,395 | 1.1 | [0.9; 1.4] | - | | |
| | | | | | | | | ||
| No | 10.5 | [9.3; 12] | 247 | 2,346 | 1.0 | | - | | |
| Yes (1 episode) | 33.3 | [27.9; 39.3] | 91 | 273 | 4.2* | [3.2; 5.7] | - | | |
| Yes (> = 2episodes) | 64.7 | [46.7; 79.3] | 22 | 34 | 15.6* | [7.3; 33] | - | ||
* p < 0.05. + Not considered in the multivariate analysis.
° Baseline category = 0.5–10 years.
∞ Include ages between 11 and 39 years.
≈ A significant interaction (OR = 5.7; 95CI [1.4; 22.7], p = 0.014) was found between age >10 years and distance <100 m.
Multivariate adjusted analysis for the risk of exposure to using survey logistic regression
| | | | | | | | | ||
| | PAV | 7.4 | [5.9; 9.3] | 83 | 1,123 | 1.0 | | 1.0 | |
| JCM | 9.6 | [7.6; 12.2] | 76 | 789 | 1.3 | [0.9; 1.9] | 1.5* | [1.02; 2.1] | |
| NP | 13.6 | [11; 16.5] | 100 | 738 | 2.0* | [1.4; 2.8] | 2.2* | [1.6; 3.2] | |
| | | | | | | | | ||
| | >250 | 10.6 | [8.7; 12.8] | 114 | 1,080 | 1.0 | | - | |
| 100–250 | 8.7 | [7.3; 10.4] | 121 | 1,388 | 0.8 | [0.6; 1.1] | - | | |
| <100 | 13.2 | [8.7; 19.5] | 24 | 182 | 1.3 | [0.8; 2.2] | - | | |
| | | | | | | | | ||
| | 0.5–5 | 3.7 | [2.9; 7.4] | 16 | 432 | 1.0 | | 1.0 | |
| 6–10 | 7.4 | [3.4; 8.0] | 30 | 404 | 2.1* | [1.1; 3.9] | 2.1* | [1.1; 3.8] | |
| 11–19 | 12.5 | [9.7; 15.9] | 61 | 490 | 3.7* | [2.1; 6.5] | 3.2*∞ | [1.9; 5.3] | |
| 20–39 | 10.3 | [8.4; 12.5] | 91 | 888 | 3.0* | [1.8; 5.0] | | | |
| > = 40 | 14.0 | [11.0; 17.6] | 61 | 436 | 4.2* | [2.4; 7.4] | 4.7* | [2.6; 8.3] | |
| | | | | | | | | ||
| | None | 6.0 | [4.2; 8.5] | 29 | 483 | 1.0 | | - | |
| Primary | 10.0 | [8.3; 12] | 105 | 1,051 | 1.7* | [1.1; 2.7] | - | | |
| Secondary | 11.1 | [9.2; 13.4] | 104 | 937 | 2.0* | [1.3; 3] | - | | |
| Superior | 11.8 | [7.8; 17.6] | 21 | 178 | 2.1* | [1.2; 3.8] | - | | |
| | | | | | | | | ||
| | None | 9.2 | [8; 10.6] | 190 | 2,064 | 1.0 | | - | |
| < 650 PEN | 11.8 | [9.1; 15.1] | 54 | 458 | 1.3 | [0.96; 1.8] | - | | |
| > = 650 PEN | 14.5 | [8.4; 23.8] | 12 | 83 | 1.7 | [0.9; 3.1] | - | | |
| | | | | | | | | ||
| | No | 9.6 | [8.4; 10.9] | 248 | 2,587 | 1.0 | | - | |
| Yes | 17.5 | [9.9; 29] | 11 | 63 | 2.0* | [1.03; 3.9] | - | | |
| | | | | | | | | ||
| | No | 9.5 | [8.3; 10.8] | 245 | 2,581 | 1.0 | | 1.0 | |
| Yes | 20.3 | [12.4; 31.4] | 14 | 69 | 2.4* | [1.3; 4.4] | 2.1* | [1.1; 3.8] | |
| | | | | | | | | ||
| | Never/Sometimes | 11.3 | [9.5; 13.4] | 141 | 1,244 | 1.0 | | - | |
| Always | 8.5 | [7.1; 10.2] | 118 | 1,392 | 0.7* | [0.6; 0.96] | - | ||
* p < 0.05.
∞ Included all ages between 11 and 39 years.
Figure 2Malaria seroprevalence curves. A: Seroprevalence curve for Plasmodium vivax. B: Seroprevalence curve for Plasmodium falciparum. Points represent observed data points, whilst the blue lines represent the maximum likelihood model and 95% confidence intervals. Estimated force of infection (λ) is plotted on the graphs. Two forces infection are plotted by likelihood ratio tests indicating change at a certain point in calendar time.
Figure 3Evolution of the annual malaria incidence, and rainfall, in Piura department: 1990–2010. Information on annual malaria cases, registered by Regional Health Direction of Piura, was obtained from the National Institute of Statistics and Informatics [27]. Numbers in the timeline point out important events that influenced malaria incidence: 1) moderate ENSO phenomenon (1991–1992), 2) first reports of chloroquine (CQ) failure for Plasmodium falciparum (since 1994), 3) very strong ENSO phenomenon (1997–1998), 4) confirmed CQ resistance for Plasmodium falciparum (1999), 5) ACT implementation (2001–2003), 6) intense droughts (2004–2007).